Funding Rounds
Ethris

Ethris Series B (2022, $26M)

Ethris

mRNA therapeutics and LNP delivery.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $26.40M

Raised Date: 2022-01-01